Plain-English translation of NCT07545811 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is a first-in-human study testing a new medication called designed to help men with advanced prostate cancer that no longer responds to standard hormone treatments. The trial is checking whether the medication is safe, what side effects it may cause, and whether it helps slow or shrink the cancer. This is one of the earliest stages of testing a new treatment in patients.
Men with advanced prostate cancer that has stopped responding to standard hormone therapy have limited treatment options and poor outcomes. This trial is exploring whether this new medication could offer another effective approach for patients who have exhausted other available therapies.
You likely qualify if…
You likely don't qualify if…
The trial has two parts: first, researchers will give increasing doses of the medication to different groups of participants to find the safest dose, and then additional participants will receive the dose that was found to be tolerable. You would receive the medication at a hospital or clinic and have regular visits for blood tests, scans, and check-ins to monitor how your body is responding and watch for any side effects. The study will assess your safety and whether the medication is helping your cancer.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States